If you require assistance, please contact our Quality Assurance Department at (512) 326-3001. Submit all new study submission forms to submissions@integreview.com. Only complete New Study Submissions will be placed on the meeting agendas.
Single Investigator Study Submission Form (revised 02/13/12)
Multiple Investigator Study Submission Form (revised 02/13/12)
Additional Principal Investigator Submission Form (revised 02/13/12) – to be completed for a Principal Investigator participating in a currently IntegReview approved multiple-investigator study.
Exempt Research (revised 7/11/11) Exempt Decision Charts
Compassionate (Expanded Access/Single Patient) Use (revised 4/12/11) – This application is to be used when submitting for approval of Expanded Access Use, (also known as “Compassionate Use”), which is a request to approve a proposal protocol and related documents to treat a patient that meets specific criteria. It is not primarily intended to be used for investigational purposes, but for treatment purposes.
Additional forms that may be required along with your submission:
Expedited Criteria Form (revised 11/29/10)
Waiver of IRB Jurisdiction Attachment (revised 11/29/10)
Additional Site Attachment (revised 11/29/10)
Waiver/Documentation of Informed Consent Form (revised 06/29/10)
Co-Principal Investigator Information Form (revised 05/4/11)
Delegated Review Criteria Form (for Canada Research only) (revised 11/01/11)
Click here to view IntegReview’s submission deadlines for full board review of Multiple Investigator and Single Investigator New Studies.